What is Mounjaro and how does it work?
Tirzepatide is the active substance in Mounjaro. It activates the receptors of two gut hormones, GIP and GLP-1. Both are involved in the body’s response to food. The medicine helps release insulin when blood glucose is high and reduces glucagon, the hormone that raises blood sugar. It also affects appetite and slows stomach emptying [1].
This effect may make you feel full sooner. People’s experiences differ. Sometimes a usual portion feels too large; at other times, getting through meals can be difficult. Eating less because you have little appetite can also reduce dietary variety and protein intake if nobody reviews your eating plan [2].
In consultations, we find that a useful question is which foods you can still manage comfortably. We look at meal times, digestive tolerance and strength, as well as weight. A small plate can still include eggs, fish, pulses or plain yoghurt. The choice depends on what you tolerate and your needs.
If your appetite decreases, every meal matters for looking after your nutrition and strength.
Mounjaro belongs to the group of treatments covered in our guide to GLP-1 medicines. If you would like to learn more about the molecule, read the tirzepatide guide.
Who is it authorised for in Spain?
The indication depends on the reason for treatment. The authorisation for type 2 diabetes includes adults and children aged 10 and over. The indication for weight management is for adults only [1].
| Reason | Who may receive it according to the product information | Condition |
|---|---|---|
| Type 2 diabetes that is not sufficiently controlled | Adults, adolescents and children aged 10 and over | Together with diet and exercise: on its own when metformin is unsuitable because of intolerance or a contraindication, or added to other diabetes medicines [1] |
| Weight management | Adults | Together with a reduced-calorie diet and increased physical activity, with an initial body mass index of 30 kg/m² or more, or from 27 to under 30 kg/m² with a weight-related health problem [1] |
The indication for children and adolescents is type 2 diabetes, never weight management. In children and adolescents, the maximum dose and monitoring also differ from those for adults [1]. If you are seeking nutritional support for a child or adolescent, a separate paediatric assessment is needed.
The fact that several people around you use it does not tell you whether it is right for you. Your doctor reviews your goals, medical history, other treatments and possible risks. If you use insulin or a sulphonylurea, they should monitor you particularly closely for low blood glucose [1]. We support your eating habits once the medical decision has been made.
What do doses of 2.5, 5, 10 and 15 mg mean?
The adult starting dose in the product information is 2.5 mg once a week. After four weeks, it increases to 5 mg. If a further increase is needed, the increments are 2.5 mg, with at least four weeks at each dose level [1]. This information helps you understand your prescription; it is not an instruction to change it.
- 2.5 mg once a week is the starting dose [1]
- 5 mg may be a maintenance dose in adults [1]
- 7.5 and 12.5 mg are intermediate steps when an increase is indicated [1].
- 10 and 15 mg are also adult maintenance doses; 15 mg is the maximum weekly dose [1].
For type 2 diabetes from the age of 10, the maintenance doses are 5 and 10 mg; 10 mg is the maximum weekly dose for children and adolescents [1]. An adult’s dosing schedule must not be applied to a child or adolescent.
If digestive symptoms get worse, speak to your prescriber before the next dose increase. Do not move up a dose level sooner or use a pen of a different strength to create your own dosing schedule.
A higher dose is not necessarily a better choice for you. The product information lists several maintenance doses, and your doctor weighs up benefits, symptoms and goals [1]. If you are advised to stay on a low dose, ask what the aim is and when it will be reviewed.
Tirzepatide slows stomach emptying, and the product information recommends monitoring oral medicines with a narrow therapeutic index, such as warfarin or digoxin, particularly when starting treatment and increasing the dose [1]. The Spanish product information does not call for an adjustment to the dose of oral contraceptives, although it recommends that women of childbearing potential use contraception during treatment [1]. Always discuss this with your prescriber; do not adjust any medicine yourself.
How much does Mounjaro cost, and is it funded by the public health system?
Mounjaro is not covered by public funding. In December 2025, the Interministerial Commission on Medicine Prices proposed that its KwikPen devices should not be included in public healthcare [3]. It cited the budget impact and the need to rationalise spending. The Spanish Ministry of Health’s medicines catalogue lists it as not funded [4].
This means you pay the full amount at the pharmacy, even if a doctor working in the public health system writes the prescription: no public health system co-payment; it is not funded. The situation may change, so check when you receive your prescription [4].
The price depends on the dose and presentation: €207.91 – €446.07. This is an indicative range: we have not been able to verify it by national product code using a publicly available official source. To find out the exact amount, ask the pharmacy about the presentation on your prescription.
To compare the funding and cost of other treatments, see our guide to GLP-1 prices in Spain. In a consultation, we can help you plan your eating around a realistic budget, without getting involved in prescribing.
What side effects may occur?
Digestive side effects are the most common. Nausea and diarrhoea are listed as very common in the product information. In weight-management trials, vomiting, abdominal pain and constipation are also very common [1].
Nausea, vomiting and diarrhoea occur more often when the dose is increased and usually ease over time [1]. Overall frequency figures cannot predict what will happen to you.
| Effect | Frequency with Mounjaro | When it occurs | What may help with food and drink |
|---|---|---|---|
| Nausea | Very common [1] | More common when the dose is increased; usually eases afterwards [1] | Smaller portions; eat slowly; avoid very fatty meals if they make symptoms worse |
| Diarrhoea | Very common [1] | More common when the dose is increased; usually eases afterwards [1] | Drink regularly; choose foods you tolerate; seek advice if you cannot stay hydrated |
| Vomiting | Very common for weight management; common for type 2 diabetes [1] | More common when the dose is increased; usually eases afterwards [1] | Stop eating when you feel full; keep an eye on hydration |
| Constipation | Very common for weight management; common for type 2 diabetes [1] | No single timeframe is given in the product information | Water and fibre introduced gradually, according to tolerance |
| Abdominal pain | Very common for weight management; common for type 2 diabetes [1] | No single timeframe is given in the product information | Notice whether it is linked to large meals; seek advice if it is severe or persistent |
These measures may make meals easier to manage, but they do not replace a medical assessment if symptoms persist.
What should you eat while taking Mounjaro?
With a smaller appetite, a balanced diet still needs protein, vegetables, fruit, carbohydrate-containing foods and usual sources of fat. A high-protein yoghurt can be part of it, but it does not replace a varied diet. Nutritional advice and strength training are among the recommendations made by scientific societies [2].
If a large meal makes you feel sick, try a smaller portion and eat again when you feel better. A simple example is an omelette with bread and tomato. Another is lentils with vegetables and a little rice. If cold food is easier to tolerate, plain yoghurt with fruit and oats may be practical.
Nausea can make it harder to drink. Keep water nearby and spread your fluids throughout the day. If vomiting or diarrhoea means you cannot drink, follow the warning advice below. Avoid turning feeling unwell into a permanent list of foods you have cut out.
What we see in consultations
“I’ve been told to eat high-protein yoghurts” is a common question. We look at the rest of the day before adding products. Sometimes whole meals are missing; at other times, most of the protein is eaten at just one meal. We also ask about strength, digestion and your relationship with food.
In consultations, we adapt what you eat to what you can tolerate. If breakfast is difficult, perhaps you could have toast with egg later. If meat feels too heavy, there are fish, pulses, tofu and dairy foods. Our guide to what to eat with GLP-1 treatment and its weekly menu offers ideas for planning the week.
Weight loss can also include loss of lean mass. Professional societies recommend monitoring strength, function and body composition, as well as meeting nutritional needs [2]. In our guide to protein and muscle with GLP-1, we explain how to combine food and strength training without promising that all muscle can be preserved.
A first step for this week: notice which meal you are leaving unfinished and look for a protein-containing option that you can tolerate.
What happens if you reduce the dose or stop taking Mounjaro?
Maintenance treatment is part of the indication for weight management [1]. Your doctor may suggest continuing on a maintenance dose and reviewing your response. That decision depends on your circumstances. A “low dose” does not mean that your weight is guaranteed to stay the same on its own.
In a withdrawal trial, people who continued tirzepatide maintained more of their weight loss than those who switched to placebo. The study’s primary aim was to compare weight maintenance after continuing or withdrawing the medicine [5]. Its results cannot predict how much weight any one person will regain.
If you are thinking about stopping, speak to your prescriber before changing your treatment. Agree how your blood glucose will be monitored if you have diabetes, and what you will review about your appetite. From a nutritional perspective, we work on sustainable meals, strength and routines that can continue afterwards. Weight regain can happen despite this work; it is not a personal failure.
The guide to weight regain after GLP-1 treatments explains how to prepare for this stage. Although its title mentions Ozempic and Wegovy, questions about stopping treatment are also relevant if you have been prescribed tirzepatide.
When might it not be suitable?
The only contraindication in the product information is an allergy to tirzepatide or any of its ingredients. In other situations, the product information advises caution or a medical assessment beforehand [1].
- Pregnancy: the product information does not recommend its use during pregnancy or if you could become pregnant and are not using contraception. If you are planning a pregnancy, your prescriber will stop it at least one month beforehand [1].
- Breastfeeding: after a single 5 mg dose, transfer into breast milk ranged from undetectable to very low; discuss this with your doctor [1].
- Previous pancreatitis or severe digestive disease, such as severe gastroparesis: caution is advised [1].
- Diabetic retinopathy requiring treatment or macular oedema: caution and eye monitoring are advised [1].
- An operation or procedure involving deep sedation: tell the team that you use it, because your stomach may not be empty [1].
If you have or have had an eating disorder, tell your doctor and mental health professional before starting a GLP-1 medicine. Scientific societies recommend assessing this history before treatment begins [2]. At Alimmenta, our Psychology team supports this aspect alongside nutritional care.
None of these situations can be resolved with a general list: your doctor will review the whole picture. In nutrition consultations, we adapt your eating plan once there is a shared clinical plan.
If you live in Latin America
The Spanish authorisation and funding by Spain’s National Health System do not describe the situation in another country. Registered presentations, indications, prescription requirements and coverage may vary in Mexico, Argentina or Colombia. Check the information with your country’s health authority and the professional caring for you.
| Country | What to check locally |
|---|---|
| Mexico | Registration, available presentation and prescription requirements |
| Argentina | Registration, available presentation and coverage |
| Colombia | Registration, available presentation and coverage |
If you already have a prescription and live outside Spain, we can support you online with your eating habits. For dosing and medical follow-up, continue to coordinate with your prescriber in your country.
Frequently asked questions about Mounjaro
Are Mounjaro and Ozempic the same?
No. Mounjaro contains tirzepatide and acts on GIP and GLP-1 receptors [1]. Ozempic contains semaglutide and acts on GLP-1 [8]. They also have different authorised indications in Spain. Your doctor will assess which is appropriate for your circumstances; the choice is not based on what people you know say.
What do we think if lots of people we know are taking it?
We understand why you are curious. Someone else’s experience does not replace an assessment of the indication, your medical history and follow-up. We support your eating habits during and after treatment.
Can I buy Mounjaro without a prescription?
No. It is a prescription-only medicine [1]. An offer without a prescription makes it impossible to check that it is being supplied through the proper healthcare channels and carries additional risks. If you have questions about access, speak to your doctor and pharmacist.
Does “Mounjaro face” mean the medicine damages your face?
The phrase usually describes visible changes after weight loss. It is not a diagnosis or a side effect listed in the product information. It is helpful to consider changes in weight, nutrition and strength, rather than focusing only on appearance.
Is one high-protein yoghurt enough to prevent muscle loss?
No single food can guarantee this. We review your protein intake across the day, the variety in your eating plan and strength training. If you are eating very little or feel weak, ask for an individual assessment [2].
If you have questions about irregular offers, read the risks of buying GLP-1 treatments without a prescription. If you would like support with eating during treatment, find out about our GLP-1 nutrition support in Barcelona and online.
When to see a doctor
When to see a doctor
When you are taking a GLP-1 medicine, we support your nutrition during and after treatment: eating enough protein, maintaining muscle and doing strength training. We also work on habits that can help support your weight when you stop taking it.
We do not prescribe medicines, adjust doses or replace your prescriber. If the medicine is causing you problems, speak to your doctor.
Arrange a medical appointment without waiting to change your diet if you notice any of the following:
- Severe, persistent pain in the upper abdomen that spreads to your back, with vomiting [1].
- If you are vomiting or have diarrhoea and cannot drink or keep fluids down, contact a healthcare professional today [1].
- Pain in the upper right-hand side of your abdomen, yellowing of the skin or eyes, or very pale stools [1].
- If you have diabetes and take insulin or medicines that can lower your blood sugar too much, seek advice if you have episodes of low blood sugar [6].
- Your vision has changed and you have diabetic retinopathy [1]
- You are losing weight very quickly, with marked weakness and loss of strength [7].
What to do. If you have pain that spreads to your back together with vomiting, go to A&E today or call 112: this could be pancreatitis (inflammation of the pancreas). If you have pain in the upper right-hand side of your abdomen, yellowing of the skin or eyes, or very pale stools, also go to A&E today. If you cannot drink, contact your doctor today; if you are also dizzy when standing up or are passing very little urine, go to A&E. If you have severe low blood sugar (confusion, being unable to swallow or needing help from someone else), call 112. If your blood sugar is mildly low or your vision has changed, contact your prescriber today or tomorrow. If you suddenly lose your vision, go to A&E. If you are losing weight very quickly and feel weak, contact your doctor this week: strength and protein are addressed, and your treatment plan is reviewed.
Most troublesome GLP-1 side effects are digestive, temporary and manageable. These are the few warning signs that mean you should stop and seek advice.
Sources
- [1] Agencia Española de Medicamentos y Productos Sanitarios (AEMPS). Ficha técnica de Mounjaro (tirzepatida). CIMA; accessed September 2026. Product information.
- [2] Mozaffarian D, Agarwal M, Aggarwal M, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. American Journal of Clinical Nutrition. 2025;122(1):344–367. doi:10.1016/j.ajcnut.2025.04.023.
- [3] Comisión Interministerial de Precios de los Medicamentos. Acuerdos de la sesión 265, 17 de diciembre de 2025; acuerdos denegatorios, alegaciones, Mounjaro KwikPen. Ministerio de Sanidad; 2025. Official agreements.
- [4] Ministerio de Sanidad. Nomenclátor: Mounjaro 10 mg/dosis KwikPen solución inyectable en pluma precargada (CN 764822), “No financiado por resolución”. Ministerio de Sanidad; accessed September 2026. Funding information.
- [5] Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024;331(1):38–48. doi:10.1001/jama.2023.24945.
- [6] American Diabetes Association Professional Practice Committee. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1). doi:10.2337/dc26-S006.
- [7] Lecube A, Azcona C, Azriel S, et al. Guía española del manejo integral y multidisciplinar de la obesidad en personas adultas (GIRO), 2nd edition, version 2.0. Sociedad Española para el Estudio de la Obesidad (SEEDO); 2025. GIRO guideline.
- [8] Agencia Española de Medicamentos y Productos Sanitarios (AEMPS). Ficha técnica de Ozempic (semaglutida). CIMA; accessed September 2026. Product information.
Written and reviewed by

Alimmenta's GLP-1 programme
Make sure what you lose is fat, and that it lasts when you stop
We support you from the first dose until a year after you stop: protein, digestive symptoms, strength, body composition and an exit plan.
- Assessmentbefore you start
- Dose escalationweeks 0-16
- Active weight lossmonths 4-12
- Plateau and maintenancefrom month 12
- Landingup to a year after stopping
4.9 ★ Google5.0 Doctoralia2,072 reviews23,000+ patients
First visit · 45 min, in clinic or online
First visit €65
Recommended for a long treatment
10-visit pack · €550
€55 per visit. How long each phase lasts depends on you.
We don't prescribe or change your dose: your doctor does that. We work alongside them.

Your first 16 weeks on a GLP-1
- What to eat at each dose increase
- 7-day menu with five small meals
- How to protect your muscle and what to do about side effects
Where should we send it?
Free PDF, in your inbox in a moment.
Data controller: Alimmenta Tu Vida, S.L. Purpose: to send you the guide and, only if you tick the second box, tips by email on the topic. You can withdraw your consent and exercise your rights at [email protected]. Legal basis, recipients and retention periods are in our privacy policy.
Before booking, you may want to read

Tirzepatide: what it is and which brand it is sold under in Spain
If tirzepatide has been suggested to you, you may want to know how it differs from semaglutide and…

Ozempic, Wegovy and Mounjaro: how are they different?
You may have heard of Ozempic, Wegovy and Mounjaro and wonder whether they are the same, and why…

Protein and muscle with Ozempic or Mounjaro: how to look after muscle mass
Your weight is going down, but you are worried about losing strength and ending up weaker than you…

Saxenda (liraglutide): how to use it, side effects and what to eat
If Saxenda has been suggested to you, you may be concerned about injecting every day, feeling sick or…
ConsultationNutrition support with GLP-1 (Ozempic, Wegovy) in Barcelona and online
The medicine takes away your appetite. What you eat even when you have less appetite, and what happens…
Book a visit →






